- Home
- SDA vs LAB Comparison
SDA vs LAB Comparison
Compare SDA & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDA
- LAB
- Stock Information
- Founded
- SDA 2007
- LAB 1999
- Country
- SDA China
- LAB United States
- Employees
- SDA N/A
- LAB N/A
- Industry
- SDA Blank Checks
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- SDA Finance
- LAB Industrials
- Exchange
- SDA Nasdaq
- LAB Nasdaq
- Market Cap
- SDA 266.9M
- LAB 473.2M
- IPO Year
- SDA N/A
- LAB 2011
- Fundamental
- Price
- SDA $2.67
- LAB $1.37
- Analyst Decision
- SDA Buy
- LAB Buy
- Analyst Count
- SDA 1
- LAB 2
- Target Price
- SDA $3.50
- LAB $2.50
- AVG Volume (30 Days)
- SDA 70.6K
- LAB 1.2M
- Earning Date
- SDA 09-12-2025
- LAB 10-29-2025
- Dividend Yield
- SDA N/A
- LAB N/A
- EPS Growth
- SDA N/A
- LAB N/A
- EPS
- SDA N/A
- LAB N/A
- Revenue
- SDA $458,905,000.00
- LAB $172,271,000.00
- Revenue This Year
- SDA $20.77
- LAB N/A
- Revenue Next Year
- SDA $19.32
- LAB N/A
- P/E Ratio
- SDA N/A
- LAB N/A
- Revenue Growth
- SDA 24.15
- LAB 76.33
- 52 Week Low
- SDA $2.12
- LAB $0.92
- 52 Week High
- SDA $11.74
- LAB $2.32
- Technical
- Relative Strength Index (RSI)
- SDA 58.74
- LAB 58.09
- Support Level
- SDA $2.60
- LAB $1.27
- Resistance Level
- SDA $2.82
- LAB $1.41
- Average True Range (ATR)
- SDA 0.20
- LAB 0.08
- MACD
- SDA 0.01
- LAB 0.01
- Stochastic Oscillator
- SDA 57.38
- LAB 80.95
About SDA SunCar Technology Group Inc.
SunCar Technology Group Inc operates digital automotive aftersales market service platform and vehicle insurance technology platform. It develops and operates online platforms that connect drivers in China with a range of aftermarket automotive services and insurance coverage options from a nationwide network of service providers. These comprehensive digital systems are built on SunCar's multi-tenant, cloud-based platform.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.